GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » 10-Year ROIIC %

Xvivo Perfusion AB (OSTO:XVIVO) 10-Year ROIIC %

: -0.17% (As of Dec. 2023)
View and export this data going back to 2012. Start your Free Trial

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Xvivo Perfusion AB's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was -0.17%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Xvivo Perfusion AB's 10-Year ROIIC % or its related term are showing as below:

OSTO:XVIVO's 10-Year ROIIC % is ranked worse than
53.5% of 800 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs OSTO:XVIVO: -0.17

Xvivo Perfusion AB 10-Year ROIIC % Historical Data

The historical data trend for Xvivo Perfusion AB's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year ROIIC %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.17

Xvivo Perfusion AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
10-Year ROIIC % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.17

Competitive Comparison

For the Medical Devices subindustry, Xvivo Perfusion AB's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xvivo Perfusion AB 10-Year ROIIC % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's 10-Year ROIIC % falls into.



Xvivo Perfusion AB 10-Year ROIIC % Calculation

Xvivo Perfusion AB's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( 5.2416744 (Dec. 2023) - 7.7153752 (Dec. 2013) )/( 1601.899 (Dec. 2023) - 109.008 (Dec. 2013) )
=-2.4737008/1492.891
=-0.17%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Xvivo Perfusion AB  (OSTO:XVIVO) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Xvivo Perfusion AB 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Traded in Other Exchanges
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines